Migraine Patch Maker NuPathe Inc. Files for $86.3M IPO

Published: May 17, 2010

Businessweek -- Specialty pharmaceutical company NuPathe Inc., which is developing a patch that treats migraines, on Friday filed for an initial public offering valued at up to $86.3 million.

Back to news